Literature DB >> 25869073

Suppression of liver receptor homolog-1 by microRNA-451 represses the proliferation of osteosarcoma cells.

Zhiyong Li1, Shuwen Wu1, Shouzheng Lv1, Huili Wang1, Yong Wang1, Qiang Guo2.   

Abstract

Liver receptor homolog-1 (LRH-1) plays an important role in the onset and progression of many cancer types. However, the role of LRH-1 in osteosarcoma has not been well investigated. In this study, the critical role of LRH-1 in osteosarcoma cells was described. Quantitative polymerase chain reaction and Western blot analysis results revealed that LRH-1 was highly overexpressed in osteosarcoma cells. LRH-1 was knocked down by small interfering RNA (siRNA), and this phenomenon significantly inhibited osteosarcoma cell proliferation. Bioinformatics analysis results showed that LRH-1 contained putative binding sites of microRNA-451 (miR-451); this result was further validated through a dual-luciferase activity reporter assay. miR-451 was overexpressed in osteosarcoma cells through transfection of miR-451 mimics; miR-451 overexpression then significantly inhibited LRH-1 expression and cell proliferation. The loss of LRH-1 by siRNA or miR-451 mimics significantly impaired Wnt/β-catenin activity, leading to G0/G1 cell cycle arrest. Results showed that LRH-1 is implicated in osteosarcoma. Therefore, miR-451-induced suppression of LRH-1 can be a novel therapy to treat osteosarcoma.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cell proliferation; Liver receptor homolog-1; Osteosarcoma; microRNA-451

Mesh:

Substances:

Year:  2015        PMID: 25869073     DOI: 10.1016/j.bbrc.2015.04.013

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

Review 2.  Toward the promise of microRNAs - Enhancing reproducibility and rigor in microRNA research.

Authors:  Kenneth W Witwer; Marc K Halushka
Journal:  RNA Biol       Date:  2016-09-19       Impact factor: 4.652

3.  Tumor suppressor activity of miR-451: Identification of CARF as a new target.

Authors:  Ling Li; Ran Gao; Yue Yu; Zeenia Kaul; Jia Wang; Rajkumar S Kalra; Zhenya Zhang; Sunil C Kaul; Renu Wadhwa
Journal:  Sci Rep       Date:  2018-01-10       Impact factor: 4.379

4.  Association between NR5A2 and the risk of pancreatic cancer, especially among Caucasians: a meta-analysis of case-control studies.

Authors:  Qun Chen; Hao Yuan; Guo-Dong Shi; Yang Wu; Dong-Fang Liu; Yu-Ting Lin; Lei Chen; Wan-Li Ge; Kuirong Jiang; Yi Miao
Journal:  Onco Targets Ther       Date:  2018-05-09       Impact factor: 4.147

5.  MicroRNA-219-5p Represses the Proliferation, Migration, and Invasion of Gastric Cancer Cells by Targeting the LRH-1/Wnt/β-Catenin Signaling Pathway.

Authors:  Chunsheng Li; Jingrong Dong; Zhenqi Han; Kai Zhang
Journal:  Oncol Res       Date:  2016-10-27       Impact factor: 5.574

6.  Human umbilical cord mesenchymal stem cells-derived exosomal microRNA-451a represses epithelial-mesenchymal transition of hepatocellular carcinoma cells by inhibiting ADAM10.

Authors:  Yunxiuxiu Xu; Yu Lai; Linhui Cao; Yanshan Li; Guangcheng Chen; Liang Chen; Hanqin Weng; Tao Chen; Lingyun Wang; Yibiao Ye
Journal:  RNA Biol       Date:  2020-12-31       Impact factor: 4.652

7.  The Orphan Nuclear Receptor Liver Homolog Receptor-1 (Nr5a2) Regulates Ovarian Granulosa Cell Proliferation.

Authors:  Marie-Charlotte Meinsohn; Fanny Morin; Kalyne Bertolin; Raj Duggavathi; Kristina Schoonjans; Bruce D Murphy
Journal:  J Endocr Soc       Date:  2017-12-01

8.  LRH1 as a promising prognostic biomarker and predictor of metastasis in patients with non-small cell lung cancer.

Authors:  Yuechao Liu; Ying Xing; Hongmei Wang; Shi Yan; Xinzhu Wang; Li Cai
Journal:  Thorac Cancer       Date:  2018-10-01       Impact factor: 3.500

Review 9.  miR-451: A Novel Biomarker and Potential Therapeutic Target for Cancer.

Authors:  Hua Bai; Suhui Wu
Journal:  Onco Targets Ther       Date:  2019-12-16       Impact factor: 4.147

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.